Dr. Ma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5901 E Seventh St
Long Beach, CA 90822
Summary
- Dr. Helen Ma is a hematologist and oncologist in Long Beach, CA and is affiliated with VA Long Beach and University of California Irvine. She specializes in hematologic oncology and is experienced hematology and oncology.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2017 - 2020
NYU Grossman School of MedicineResidency, Internal Medicine, 2014 - 2017
Geisel School of Medicine at DartmouthClass of 2014
Certifications & Licensure
CA State Medical License 2020 - 2026
NY State Medical License 2015 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 25 citationsT-cell lymphomas, a challenging disease: types, treatments, and futureHelen Ma, Maher Abdul-Hay
International Journal of Clinical Oncology. 2017-02-01 - 92 citationsCombined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study.Lorenzo Falchi, Helen Ma, Sandra Klein, Jennifer K. Lue, Francesca Montanari
Blood. 2020-11-10 - 16 citationsThe peripheral T-cell lymphomas: an unusual path to cure.Helen Ma, Enrica Marchi, Owen A. O'Connor
The Lancet. Haematology. 2020-10-01
Abstracts/Posters
- Belinostat Induces High Overall Response Rate (ORR) in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)Helen Ma, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Novel Drugs and Clinical Trial-Based Treatments Prolong Survival of Peripheral T-Cell Lymphomas (PTCL) Patients: Single Institution Retrospective Analysis61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Survival outcomes of patients with peripheral T-cell lymphomas (PTCL) treated with chemotherapy and/or novel agents: The Columbia University experience.2019 ASCO Annual Meeting - 6/1/2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
